help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on August 29, 2006
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2005-2830
A more recent version of this article appeared on November 1, 2006
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
91/11/4381    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jochberger, S.
Right arrow Articles by Dünser, M. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jochberger, S.
Right arrow Articles by Dünser, M. W.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

Submitted on December 29, 2005
Accepted on August 23, 2006

COPEPTIN AND ARGININE VASOPRESSIN CONCENTRATIONS IN CRITICALLY ILL PATIENTS

Stefan Jochberger MD*, Nils G. Morgenthaler MD, Viktoria D. Mayr MD, Günter Luckner MD, Volker Wenzel MD, Hanno Ulmer PhD, Siegfried Schwarz MD, Walter R. Hasibeder MD, Barbara E. Friesenecker MD, and Martin W. Dünser MD

Department of Anesthesiology, Innsbruck Medical University, Austria; Department of Research, B.R.A.H.M.S. Aktiengesellschaft, Hennigsdorf, Germany; Institute of Medical Biostatistics, Innsbruck Medical University, Austria; ,Division of Experimental Pathophysiology and Immunology, Biocenter, Innsbruck Medical University, Austria; Department of Anesthesiology and Critical Care Medicine, Krankenhaus der Barmherzigen Schwestern, Ried im Innkreis, Austria; Department of Intensive Care Medicine, University Hospital of Bern, Switzerland

* To whom correspondence should be addressed. E-mail: Stefan.Jochberger{at}uibk.ac.at.

Context: Determination of arginine vasopressin (AVP) concentrations may be helpful to guide therapy in critically ill patients. A new assay analyzing copeptin, a stable peptide derived from the AVP precursor, has been introduced.

Objective: Determination of plasma copeptin concentrations.

Design: Post-hoc analysis of plasma samples and data from a prospective study.

Setting: Twelve-bed general and surgical intensive care unit (ICU) in a tertiary university teaching hospital.

Patients: Seventy healthy volunteers and 157 ICU patients with sepsis, SIRS, and after cardiac surgery.

Interventions: None.

Main Outcome Measures: Copeptin plasma concentrations 24 h after ICU admission. Demographic data, AVP plasma concentrations, and a multiple organ dysfunction syndrome score were documented at the same time.

Results: AVP (P < 0.001) and copeptin (P < 0.001) concentrations were significantly higher in ICU patients than in controls. Patients after cardiac surgery had higher AVP (P = 0.003) and copeptin (P = 0.003) concentrations than patients with sepsis or SIRS. Independent of critical illness, copeptin and AVP correlated highly significantly with each other. Critically ill patients with sepsis and SIRS exhibited a significantly higher ratio of copeptin/AVP plasma concentrations than patients after cardiac surgery (P = 0.012). The American Society of Anesthesiologists' classification (P = 0.046) and C-reactive protein concentrations (P = 0.006) were significantly correlated with the copeptin/AVP ratio.

Conclusions: Plasma concentrations of copeptin and AVP in healthy volunteers and critically ill patients correlate significantly with each other. The ratio of copeptin/AVP plasma concentrations is increased in patients with sepsis and SIRS, suggesting that copeptin may overestimate AVP plasma concentrations in these patients.


Key words: Copeptin • Vasopressin • Plasma Concentrations • Critically Ill Patients




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
S. Neuhold, M. Huelsmann, G. Strunk, B. Stoiser, J. Struck, N. G. Morgenthaler, A. Bergmann, D. Moertl, R. Berger, and R. Pacher
Comparison of Copeptin, B-Type Natriuretic Peptide, and Amino-Terminal Pro-B-Type Natriuretic Peptide in Patients With Chronic Heart Failure: Prediction of Death at Different Stages of the Disease
J. Am. Coll. Cardiol., July 22, 2008; 52(4): 266 - 272.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Szinnai, N. G. Morgenthaler, K. Berneis, J. Struck, B. Muller, U. Keller, and M. Christ-Crain
Changes in Plasma Copeptin, the C-Terminal Portion of Arginine Vasopressin during Water Deprivation and Excess in Healthy Subjects
J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 3973 - 3978.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
M. Christ-Crain and B. Muller
Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators
Eur. Respir. J., September 1, 2007; 30(3): 556 - 573.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society